ERCC1 and small cell lung carcinoma: Moreover, in a large retrospective study of 184 SCLC patients, the low expression of ERCC1, as part of a favorable expression signature, was significantly correlated with better PFS and OS in both limited disease (LD) and ED-SCLC [16].